Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

846
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
846

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of intestinal adaptation in short bowel syndrome: what is the evidence?

Gut·2026
Same author

Metabolic balance studies: A comprehensive protocol and methodological approach for assessing intestinal function.

Intestinal Failure (New York, N.Y.)·2026
Same author

Beyond Sarcopenia: A Systematic Review and Meta-Analysis on Muscle Outcomes After Bariatric Surgery.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

Functional Dyspepsia.

The New England journal of medicine·2026
Same author

Can Disorders of Gut-Brain Interaction be Quantified in Systemic Sclerosis Without Excluding Dysmotility?

Neurogastroenterology and motility·2026
Same author

Advanced Age-Related Changes in Intestinal Drug Transporters and Metabolising Enzymes: A Targeted Proteomics Study.

Molecular pharmaceutics·2026

Related Experiment Video

Updated: Nov 27, 2025

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
09:44

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

22.6K

Animal Models for Functional Gastrointestinal Disorders.

Alison Accarie1, Tim Vanuytsel1,2

  • 1Department of Chronic Diseases, Metabolism and Ageing (ChroMetA), Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.

Frontiers in Psychiatry
|December 2, 2020
PubMed
Summary

Animal models are crucial for understanding functional gastrointestinal disorders (FGID) like functional dyspepsia and irritable bowel syndrome. This review details stress, infection, and food-related models to explore FGID pathophysiology and brain-gut axis dysfunction.

Keywords:
animal modelsfunctional dyspepsiafunctional gastrointestinal disordersintestinal permeabilityirritable bowel syndromemast cellsstressvisceral pain

More Related Videos

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

888
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.3K

Related Experiment Videos

Last Updated: Nov 27, 2025

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
09:44

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

22.6K
Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

888
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.3K

Area of Science:

  • Gastroenterology
  • Neuroscience
  • Pharmacology

Background:

  • Functional gastrointestinal disorders (FGID), including functional dyspepsia (FD) and irritable bowel syndrome (IBS), present chronic abdominal symptoms without clear organic causes.
  • The pathophysiology of FGID remains incompletely understood, necessitating advanced research tools.
  • Animal models are instrumental in elucidating FGID mechanisms and evaluating therapeutic interventions.

Purpose of the Study:

  • To review and categorize diverse animal models used in FGID research.
  • To highlight the utility of these models in understanding the brain-gut axis and peripheral gastrointestinal mechanisms.
  • To discuss models relevant to FGID comorbidities like anxiety and depression.

Main Methods:

  • Review of stress-related animal models: perinatal, neonatal (maternal separation), and adult stress paradigms.
  • Examination of models targeting peripheral gastrointestinal mechanisms: infection-induced, inflammatory triggers, food hypersensitivity, and metabolic disorders.
  • Inclusion of models of secondary FGID and spontaneous models exhibiting GI and anxiety-related symptoms.

Main Results:

  • Stress models provide insights into brain-gut axis dysfunction in FGID.
  • Peripheral models elucidate gastrointestinal mechanisms, including those triggered by infection, inflammation, and food.
  • Spontaneous and secondary models offer valuable perspectives on FGID comorbidities and complex etiologies.

Conclusions:

  • A comprehensive array of animal models aids in unraveling the complex pathophysiology of FGID.
  • These models are essential for investigating the brain-gut axis, peripheral factors, and associated comorbidities.
  • Continued development and application of animal models will advance the understanding and treatment of FGID.